Valganciclovir Tablet, Film Coated
Product Images NDC 64380-153

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 64380-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (090c23ad 1044 4f4c 9de4 1ca5bf487847 01)

This appears to be a medical or laboratory report. The text contains a formula to calculate the Schwartz Creatinine Clearance based on a person's height and serum creatinine level. The formula includes units of measurement in milliliters per minute and per 1.73 square meters. Additionally, the report mentions "BSA," which likely refers to body surface area, and "P8" which may be a typo or abbreviation for another quantity that is not clear from the context.*

FDA Label Image

Estimated Creatinine Clearance (090c23ad 1044 4f4c 9de4 1ca5bf487847 02)

This is a formula to estimate the glomerular filtration rate (GFR) for males and females based on their age, body weight, and serum creatinine levels. The formula is different for males and females, with the female value being 0.85 multiplied by the male value.*

FDA Label Image

Image (090c23ad 1044 4f4c 9de4 1ca5bf487847 03)

FDA Label Image

Image (090c23ad 1044 4f4c 9de4 1ca5bf487847 04)

This is a label with a size of 112 inches x 45 inches, which corresponds to A size. It has a nonvarnished area and a non-printing dieline indicated by '/'. The label also mentions "Eramie Tablets, USP". Additionally, the label size is given as 117.475mm x 35.1mm.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.